Cytosorbents Corp reports results for the quarter ended in June - Earnings Summary
13/08/2024 22:01
* Cytosorbents Corp CTSO.OQ reported a quarterly adjusted
loss
of 8 cents per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of -14 cents. The mean expectation of four analysts for the
quarter was for a loss of 10 cents per share. Wall Street
expected results to range from -11 cents to -9 cents per share.
* Revenue rose 5% to $9.89 million from a year ago; analysts
expected $9.68 million.
* Cytosorbents Corp's reported EPS for the quarter was a
loss of 8
cents.
* The company reported a quarterly loss of $4.14 million.
* Cytosorbents Corp shares had risen by 26.8% this
quarter and
lost 19.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 12.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Cytosorbents Corp
is $3.50
This summary was machine generated from LSEG data August 13 at
09:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.10 -0.08 Beat
Mar. 31 2024 -0.12 -0.12 Met
Dec. 31 2023 -0.14 -0.13 Beat
Sep. 30 2023 -0.14 -0.21 Missed